根据 7 位华尔街分析师的预测,Apyx Medical Inc 的收入预期范围从 $12.34M 到 $10.16M
Apyx Medical Inc 的盈利质量评分是多少?
Apyx Medical Inc 的盈利质量评分为 B+/56.574394。该评分基于盈利能力、增长、现金生成与资本分配以及杠杆四个维度。
Apyx Medical Inc 何时发布财报?
Apyx Medical Inc 的下一份财报预计在 2026-06-08 发布
Apyx Medical Inc 的预期收益是多少?
根据华尔街分析师的预测,Apyx Medical Inc 的预期收益为 $18.76M
Apyx Medical Inc 是否超出收益预期?
Apyx Medical Inc 最近的收益为 $19.16M,超出预期 预期。
关键数据
前收盘价
$3.98
开盘价
$3.97
当日区间
$3.9 - $4.18
52周范围
$0.755 - $4.5
交易量
293.3K
平均成交量
128.1K
股息收益率
--
每股收益(TTM)
-0.27
市值
$161.5M
什么是 APYX?
Apyx Medical Corp. operates as an energy-based medical technology company. The company is headquartered in Clearwater, Florida and currently employs 220 full-time employees. Its segments include Advanced Energy and Original Equipment Manufacturer (OEM). The Advanced Energy segment’s product portfolio consists of its Helium Plasma Technology that is marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. The company focuses on the cosmetic surgery market, where Renuvion offers plastic surgeons, facial plastic surgeons and cosmetic physicians the ability to provide controlled heat to the tissue to achieve their desired results. These product lines consist of a multifunction generator, a handpiece and a supply of helium gas. Through OEM agreements, the OEM segment, designs, develops and manufactures electrosurgical equipment and medical devices by producing generators, medical devices and related accessories for medical device manufacturers as well as start-up businesses in need of its energy-based designs.